Christopher Corless, M.D., Ph.D.

Executive Director and Chief Medical Officer, Knight Diagnostic Laboratories

Oregon Health & Science University

Professor of Pathology, OHSU

Biographical Sketch

Dr. Corless received his M.D. and Ph.D. from Washington University in St. Louis, Mo. He did his residency training in anatomic pathology at Brigham & Women's Hospital in Boston, Mass., where he also completed fellowships in gastrointestinal and genitourinary pathology.  Dr. Corless is board certified in anatomic pathology.  He joined the faculty of Oregon Health & Science University in 1994 and became professor of pathology in 2004.

Dr. Corless has served as the residency program director in the Department of Pathology and medical director of surgical pathology for OHSU Hospital.  In addition to practicing surgical pathology, Dr. Corless has expertise in applying molecular diagnostics to the classification and prognostication of solid tumors.  He has a longstanding research interest in gastrointestinal stromal tumors (GISTs), as well as in bringing new technologies into clinical use.  Dr. Corless has authored or coauthored more than 200 publications.

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More